BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND GOPC, FIG, 57120, ENSG00000047932, GOPC1, Q9HD26, CAL, dJ94G16_2 PIST AND Prognosis
19 results:

  • 1. Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.
    Smoots SG; Schreiber AR; Jackson MM; Bagby SM; Dominguez ATA; Dus ED; Binns CA; MacBeth M; Whitty PA; Diamond JR; Pitts TM
    Breast Cancer Res; 2024 Mar; 26(1):35. PubMed ID: 38429789
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Intraoperative evaluation of metastases in sentinel nodes through one-step nucleic acid amplification: Initial experience in a single institution.
    Pohlodek K; Feriancova M; Kotvanova K; Meciarova I
    Bratisl Lek Listy; 2023; 124(3):163-169. PubMed ID: 36598305
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Systematic screening identifies a TEAD4-S100A13 axis modulating cisplatin sensitivity of oral squamous cell carcinoma cells.
    Li R; Li W; He F; Zhang M; Luo H; Tang H
    J Oral Pathol Med; 2021 Oct; 50(9):882-890. PubMed ID: 34358353
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The value of maspin and PD-L1 expression and peritumoral lymphocytic infiltration in breast tumors.
    Tuncel F; Bozkurt F; Berkesoglu M
    Bratisl Lek Listy; 2020; 121(12):894-900. PubMed ID: 33300360
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Chrysosplenol d, a Flavonol from
    Lang SJ; Schmiech M; Hafner S; Paetz C; Werner K; El Gaafary M; Schmidt CQ; Syrovets T; Simmet T
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521698
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
    Xu L; Shen J; Jia J; Jia R
    Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness.
    Revilla G; Pons MP; Baila-Rueda L; García-León A; Santos D; Cenarro A; Magalhaes M; Blanco RM; Moral A; Ignacio Pérez J; Sabé G; González C; Fuste V; Lerma E; Faria MDS; de Leiva A; Corcoy R; Carles Escolà-Gil J; Mato E
    Sci Rep; 2019 Jul; 9(1):10260. PubMed ID: 31311983
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of kisspeptin on aromatase expression in breast cancer.
    Yilmaz MB; Oksuz H; Ilgaz NS; Ocal I; Tazehkand MN
    Bratisl Lek Listy; 2018; 119(12):776-780. PubMed ID: 30686017
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Factors affecting sentinel lymph node metastasis in Turkish breast cancer patients: Predictive value of Ki-67 and the size of lymph node.
    Ozemir IA; Orhun K; Eren T; Baysal H; Sagiroglu J; Leblebici M; Ceyran AB; Alimoglu O
    Bratisl Lek Listy; 2016; 117(8):436-41. PubMed ID: 27546694
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer.
    Paksoy SE; Tasdelen I; Balaban AS; Ozkaya G; Tolunay S
    Bratisl Lek Listy; 2013; 114(11):645-9. PubMed ID: 24236435
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Adrenal metastases.
    Wagnerova H; Lazurova I; Felsoci M
    Bratisl Lek Listy; 2013; 114(4):237-40. PubMed ID: 23514559
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Aggressive treatment for hepatic metastases from breast cancer: results from a single center.
    Polistina F; Costantin G; Febbraro A; Robusto E; Ambrosino G
    World J Surg; 2013 Jun; 37(6):1322-32. PubMed ID: 23474856
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Spheroid assay to measure TGF-β-induced invasion.
    Naber HP; Wiercinska E; Ten Dijke P; van Laar T
    J Vis Exp; 2011 Nov; (57):. PubMed ID: 22126971
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Consequences of abdominal adenocarcinoma in post-menopausal woman in relation to surgical and non-surgical management.
    Moniruzzaman M; Faruquzzaman ; Mohiuddin T
    Bratisl Lek Listy; 2011; 112(8):472-4. PubMed ID: 21863621
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma.
    Vecanova J; Hodorova I; Mihalik J; Benicky M; Kluchova D; Rybarova S
    Bratisl Lek Listy; 2011; 112(2):67-70. PubMed ID: 21456504
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The effects of E-cadherin and bcl-2 on prognosis in patients with breast cancer.
    Kavgaci H; Yildiz B; Fidan E; Reis A; Ozdemir F; Cobanoglu U; Can G
    Bratisl Lek Listy; 2010; 111(9):493-7. PubMed ID: 21180263
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Chromatin texture, DNA index, and S-phase fraction in primary breast carcinoma cells analysed by laserscanning cytometry.
    Kuliffay P; Sanislo L; Galbavy S
    Bratisl Lek Listy; 2010; 111(1):4-8. PubMed ID: 20429304
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Treatment strategy of early-stage breast cancer.
    Svetlovska D; Mardiak J
    Bratisl Lek Listy; 2005; 106(11):362-5. PubMed ID: 16541622
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The primary use of endocrine therapies.
    Howell A; Anderson E; Blamey R; Clarke RB; Dixon JM; Dowsett M; Johnston SR; Miller WR; Nicholson R; Robertson JF
    Recent Results Cancer Res; 1998; 152():227-44. PubMed ID: 9928561
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.